Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma

• Shamzah Araf,
• Koorosh Korfi,
• Findlay Bewicke-Copley,
• Jun Wang,
• Sergio Cogliatti,
• Emil Kumar,
• Flavio Forrer,
• Sally F. Barrington,
• Trevor A. Graham,
• David W. Scott,
• Lisa M. Rimsza,
• Andrew Davies,
• Peter Johnson,
• Jessica Okosun,
• Jude Fitzgibbon,
• Martin Fehr

Affiliations

Shamzah Araf

Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK

Koorosh Korfi

Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK

Findlay Bewicke-Copley

Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK;Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK

Jun Wang

Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK

Sergio Cogliatti

Institute of Pathology, Cantonal Hospital St Gallen, St Gallen, Switzerland

Emil Kumar

Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK

Flavio Forrer

Department of Nuclear Medicine, Cantonal Hospital St Gallen, St Gallen, Switzerland

Sally F. Barrington

King’s College London and Guy’s and St Thomas’ PET Centre, School of Biomedical Engineering and Imaging Sciences, King’s College London, King’s Health Partners, London, UK

Trevor A. Graham

Evolution and Cancer Laboratory, Barts Cancer Institute, Queen Mary University of London, London, UK

David W. Scott

Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada

Lisa M. Rimsza

Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ, USA

Andrew Davies

Cancer Research UK Centre, University of Southampton, Southampton, UK

Peter Johnson

Cancer Research UK Centre, University of Southampton, Southampton, UK

Jessica Okosun

Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK

Jude Fitzgibbon

Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK

Martin Fehr

Clinic for Medical Oncology and Haematology, Cantonal Hospital St Gallen, St Gallen, Switzerland